Blog
A year later: New GLP-1 clinical trial results validate Truveta’s real-world data study
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through October 2024
Truveta achieves HITRUST r2 Certification
Truveta Data now includes more than 120 million de-identified patients
How real-world data is transforming GLP-1 research for diabetes and obesity care
Truveta Data used in new study exploring trends in colorectal cancer screening
New study finds youth obesity undertreated, despite new AAP guidelines
